PROGRAM FOR THE INITIATION AND DEVELOPMENT OF STATE-BASED SURVEILLANCE CAPACITY IN OCCUPATIONAL SAFETY AND HEALTH RELEASE DATE: March 21, 2002 RFA: OH-02-007 Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH), ( LETTER OF INTENT RECEIPT DATE: May 3, 2002 APPLICATION RECEIPT DATE: June 11, 2002 THIS RFA CONTAINS THE FOLLOWING INFORMATION o Purpose of the RFA o Research Objectives o Mechanism(s)of Support o Funds Available o Eligible Institutions o Individuals Eligible to Become Principal Investigations o Special Requirements o Where to Send Inquiries o Letter of Intent o Submitting an Application o Peer Review Process o Review Criteria o Receipt and Review Schedule o Award Criteria o Required Federal Citations PURPOSE OF THIS RFA The National Institute for Occupational Health and Safety (NIOSH), Centers for Disease Control and Prevention (CDC) announces the availability of funds for fiscal year (FY) 2002 for cooperative agreement (U01) applications to support the initiation/development of new state-based occupational surveillance programs. The purpose of this RFA is to establish occupational safety and health surveillance and associated activities in states without a current occupational surveillance program. This RFA is consistent with Goal #2 of the NIOSH Surveillance Strategic Plan (to strengthen the capacity of state health departments and other state agencies to conduct occupational surveillance). PROGRAM OBJECTIVES Background A comprehensive approach to surveillance has long been recognized as fundamental to the prevention of occupational diseases, injuries, and hazards. Through an ongoing, systematic collection, analysis, interpretation, and dissemination of relevant health and hazard occupational data, public health and research priorities may be established. More importantly, by linking the results from such analysis to intervention and prevention activities, significant improvements in occupational safety and health can be achieved. Due to the myriad of occupations and diverse employment profiles across states, an integrated program at the state level is a critical component of a comprehensive approach to occupational surveillance. However, only a few states have an integrated occupational surveillance program, and there is a need to develop surveillance capacity in more states. This RFA is focused on achieving this goal. NIOSH began developing a program of national occupational health surveillance activities in the early 1970s. These initial efforts involved hazard surveillance and health effects surveillance. Over the past quarter century, NIOSH has played a key role in the surveillance of occupational diseases, injuries, and hazards. The NIOSH program complements the important surveillance activities carried out by many states and several other Federal agencies, including the Bureau of Labor Statistics (BLS), the Occupational Safety and Health Administration (OSHA), the Mine Safety and Health Administration (MSHA), and the National Center for Health Statistics (NCHS). Collaboration between NIOSH and states related to occupational safety and health surveillance began with the Surveillance Cooperative Agreements between NIOSH and States (SCANS) in the 1980"s. This program was developed to increase State health department capacities in the area of occupational safety and health. Subsequent to this initial support for capacity building, NIOSH has supported a variety of state-based surveillance awards that have focused on specific disease or injury outcomes. In addition to the Sentinel Event Notification Systems for Occupational Risks (SENSOR) Program operating in 13 states and the Fatality Assessment and Control Evaluation (FACE) Program operating in 15 states, current major collaborative surveillance- related activities between NIOSH and states include the Adult Blood Lead Epidemiology and Surveillance (ABLES) Program, a program that has grown from 4 states in 1987 to 34 states in 2001. Although NIOSH has provided support for condition specific and multiple condition surveillance programs, many states have yet to develop the critical infrastructure needed to support fundamental occupational health and safety surveillance. Thus, the need still exists to provide resources to support initiation/development of state-based efforts to build occupational surveillance capacity. In 1995, the Council of State and Territorial Epidemiologists (CSTE), working in collaboration with the Association of State and Territorial Health Officials (ASTHO) and NIOSH, published guidelines regarding state-based capacity in occupational safety and health. These guidelines outlined core and comprehensive activities in occupational health and safety surveillance along with associated activities in policy development, intervention, and infrastructure. The goal of this announcement is to provide support for new states to initiate and/or develop these activities. Objectives Objectives for the initiation/development phase for state-based occupational surveillance programs may include but are not limited to the following: (1) Establish an occupational safety and health surveillance program with coordination among local public health agencies and other state partners, (2) Establish an occupational safety and health advisory committee within the State to identify and address issues relevant to injury, disease, and hazard surveillance and prevention in the state, (3) Conduct a review and analysis of existing available surveillance data within the state, (4) Develop and implement comprehensive surveillance activities and associated policy, intervention, and infrastructure activities within the state as outlined in the Minimum and Comprehensive Criteria for State-based Occupational Surveillance. As states consider the framework for surveillance activities within their states, they are encouraged to consult/collaborate with states that have current NIOSH supported surveillance programs. Since this program is intended to build state infrastructure, 25% of the funds awarded must be retained and used by the state. USEFUL REFERENCE Stanbury M. Rosenman K., and Anderson H. Guidelines: Minimum and Comprehensive State-based Activities in Occupational Safety and Health. Occupational and Environmental Health Committee. Council of State and Territorial Epidemiologists. Association of State and Territorial Health Officials. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 95- 107. (For additional information about this publication, call 1- 800-35-NIOSH.) MECHANISM OF SUPPORT The administrative and funding instrument to be used for this program will be a cooperative agreement (U01), an assistance mechanism in which substantial NIOSH scientific and/or programmatic involvement with the awardee is anticipated during performance of the activity. As an applicant, you will be solely responsible for planning, directing, and executing the proposed project. This RFA is a one-time solicitation. The total requested project period for an application submitted in response to this RFA may not exceed three (3) years. The award and level of support depend on the receipt of applications of high scientific merit. Although this program is provided for in the financial plans of NIOSH, the award, pursuant to this RFA, is contingent upon the availability of funds for this purpose. This RFA uses just-in-time concepts. This RFA uses the detailing budget format rather than the modular budget format. Under the cooperative agreement award mechanism, the Principal Investigator retains the primary responsibility and dominant role for planning, directing and executing the proposed project with NIOSH staff being substantially involved as a partner with the Principal Investigator, as described under the section, Cooperative Agreement Terms and Conditions of Award. FUNDS AVAILABLE Approximately $500,000 is available in FY 2002 to fund three to four cooperative agreement awards for a three (3) year period. The maximum amount that may be requested is $100,000 in direct costs per year. Awards are expected to begin September 30, 2002. The amount of funding available may vary and is subject to change. Awards will be made for a 12-month budget period within a project period up to three (3) years. Continuation awards within the project period will be made on the basis of satisfactory progress and availability of funds in future years. A minimum of 25 percent of the funds must be retained and used by the State. Use of Funds Applicants should include in their budgets funds for one trip per year for an annual meeting of grantees to provide an opportunity for the exchange of program and scientific information, to be held in Washington, D.C. ELIGIBLE INSTITUTIONS You may submit an application if your institution has the following characteristic: o unit of state government that directs or has responsibility for occupational health issues and that has not received a NIOSH award (other than ABLES) in the past three years. INDIVIDUALS ELIGIBLE TO BECOME PRINCIPAL INVESTIGATORS Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from under-represented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIOSH programs. Note: Title 2 of the United States Code section 1611 states that an organization described in section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting an award, grant, or loan. SPECIAL REQUIREMENTS Cooperative Agreement Terms and Conditions of Award The Terms and Conditions of Award, below, will be incorporated in all awards issued as a result of this RFA. It is critical that each applicant include specific plans for responding to these terms. These special Terms of Award are in addition to and not in lieu of otherwise applicable OMB administrative guidelines, HHS Grant Administration Regulations at 45 CFR Parts 74 and 92, and PHS Grant Administration policy statements. Under the cooperative agreement, the NIOSH purpose is to support and/or stimulate the recipient"s activity, by involvement in and otherwise working jointly with the award recipient in a partner role, but it is not to assume direction, prime responsibility, or a dominant role in the activity. Consistent with this concept, the dominant role and prime responsibility for the activity resides with the awardee(s) for the project as a whole, although specific tasks and activities in carrying out the studies will be shared among the awardees and the NIOSH collaborators where appropriate, including the following: 1. Recipient Responsibilities The recipient will coordinate project activities, scientifically and administratively, at the awardee institution (state office that administers the award) and at the other sites that may be supported by sub-contractors to this award. The applicant will have primary authority and responsibility to do the following: o establish and maintain a scientific advisory committee to identify relevant state-specific issues and priorities for occupational surveillance, o define objectives and approaches for establishing and enhancing a state-based occupational surveillance program, o establish and maintain contacts with appropriate organizations, groups and individuals who may provide or use appropriate surveillance data, o conduct a review and analysis of existing surveillance data, o develop any surveillance capacity using automated information technology tools and systems so that this capacity is in compliance with National Electronic Disease Surveillance System (NEDSS) architecture to enhance the opportunity for interoperability and to promote the use of standards across public health, and o publish surveillance results, interpretations, and conclusions under the terms and conditions of the cooperative agreement award. 2. NIOSH Responsibilities NIOSH anticipates having substantial scientific programmatic involvement during conduct of this activity. However the NIOSH role is limited to technical assistance, advice, and coordination. NIOSH will do the following: o serve as a scientific liaison between the awardee and other program staff at NIOSH with experience in the occupational health issues of State surveillance programs, o provide expert consultation in the area of surveillance and occupational epidemiology, if requested by the awardee, o provide technical advice on data collection, developing operating guidelines, quality control procedures, and developing policies/protocols for dealing with recurrent situations, if requested by the awardee, and o facilitate collaborative efforts to compile and disseminate program results through presentations and publications. WHERE TO SEND INQUIRIES We encourage inquiries concerning this RFA and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues. This RFA and other CDC Announcements can be found on the CDC Homepage ( under the Funding section (see Grants and Cooperative Agreements scroll down to Occupational Safety and Health). This RFA can also be found on the NIOSH HomePage ( under Extramural Programs, Current Funding Opportunities. Preapplication Conference Call Applicants are invited by NIOSH to attend a pre-application technical assistance conference on April 17 at 2:00 PM (Eastern time) to discuss: programmatic issues regarding this program, how to apply, and questions regarding the content of this RFA. Applicants may participate by telephone. The conference name is A NIOSH Surveillance and the telephone bridge number is 800-311- 3437. Interested parties will need the conference code, 815726, to participate. Direct inquiries regarding programmatic issues to: Lee M. Sanderson, Ph.D. Office of Extramural Programs National Institute for Occupational Safety and Health Centers for Disease Control and Prevention 1600 Clifton Road, N.E. Executive Park Building 24, Room 1429, MS E-74 Atlanta, GA 30333 Telephone: 404/498-2546 FAX: 404/498-2571 Email: Direct inquiries regarding grants management business matters to: Joe Gilchrist Contracts Management Branch Centers for Disease Control and Prevention 626 Cochrans Mill Road Pittsburgh, Pennsylvania 15236-0070 CDC Announcement Number 02065 Telephone: 412/386-6428 FAX: 412/386-6459 Email: LETTER OF INTENT Prospective applicants are asked to submit a letter of intent by May 3, 2002, that includes the following information: o Descriptive title of the proposed research o Name, address, and telephone number of the Principal Investigator o Names of other key personnel o Participating institutions o Number and title of this RFA Although a letter of intent is not required, is not binding, and does not enter into the review of an application, the information that it contains is used to estimate the potential review workload and plan the review. The letter of intent should be sent to: Gwendolyn Cattledge, Ph.D., M.S.E.H. Office of Extramural Programs National Institute for Occupational Safety and Health Centers for Disease Control and Prevention 1600 Clifton Road, N.E. Executive Park Building 24, Room 1423, MS E-74 Atlanta, GA 30333 Telephone: 404/498-2508 FAX: 404/498-2571 Email: SUBMITTING AN APPLICATION Applications must be prepared using the PHS 398 research grant application instructions and forms (rev. 5/2001). The PHS 398 is available at in an interactive format. For further assistance, contact GrantsInfo, Telephone 301/710-0267, Email: Information to prepare a detailed budget is provided in the instructions. If the proposed project involves organizations or persons other than those affiliated with the applicant organization, letters of support and/or cooperation must be included. Special Instructions Special instructions for defining proposed project plans are included in the public health service grant guidelines (PHS 398, page 15) and should address the following questions: (1) What do you intend to do, (2) Why is the work important, (3) What has already been done, and (4) How are you going to do the work. Items a-d below should be organized to address these questions in detail. a. Specific Aims. Identify the broad, long-term objectives of the proposed project and expected accomplishments. b. Background and Significance. Briefly provide relevant background information related to this project, include a critique of existing knowledge on the subject and identify information gaps that the proposed project will address. Described the scope and the nature of target condition in the applicants State. Specifically address how this project is important and relevant to public health by relating the specific aims to the broad, long- term objectives. c. Preliminary Studies/Progress Report. Pertinent preliminary studies/activities conducted by the principal investigator/program director should be included to establish past experience and competence in the project area. Include a list of references to appropriate publications and manuscripts. d. Project Design and Methods. Describe in detail the project design and methods that will be used to achieve the specific aims of the project. Specifically describe how the project design and methodology will conduct timely surveillance. Discuss potential limitations and anticipated difficulties of the proposed project and provide alternative approaches to be used to achieve the defined aims. Include a tentative timetable for the project. SENDING AN APPLICATION TO THE NIOSH: Submit a signed, typewritten original of the application, including the Checklist, and three signed photocopies, in one package to: Joe Gilchrist CDC Announcement Number: 02064 Contracts Management Branch Centers for Disease Control and Prevention 626 Cochrans Mill Road Pittsburgh, Pennsylvania 15236-0070 Telephone: 412/386-6428 FAX: 412/386-6459 Email: At the time of submission, two additional copies of the application must also be sent to: Gwendolyn Cattledge, Ph.D., M.S.E.H. Office of Extramural Programs National Institute for Occupational Safety and Health Centers for Disease Control and Prevention 1600 Clifton Road, N.E. Executive Park Building 24, Room 1423, MS E-74 Atlanta, GA 30333 Telephone: 404/498-2508 FAX: 404/498-2571 Email: APPLICATION PROCESSING: Applications must be received by June 11, 2002. If an application is received after that date, it will be returned to the applicant without review. The CDC and NIOSH will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. CDC and NIOSH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of a substantial revision of an application already reviewed, but such an application must include an introduction addressing the previous critique. PEER REVIEW PROCESS Upon receipt, applications will be reviewed for completeness by CDC and responsiveness by NIOSH. Incomplete applications will be returned to the applicant without further consideration. If the application is not responsive to the RFA, CDC staff may contact the applicant to determine whether to return the application to the applicant or submit it for review in competition with unsolicited application at the next appropriate NIH review cycle. Applications that are complete and responsive to the RFA will be evaluated for scientific and technical merit by a scientific review group convened by NIOSH in accordance with the review criteria stated below. As part of the initial merit review, all applications will: o Receive a written critique, o Undergo a process in which only those applicants deemed to have the highest scientific or technical merit, generally the top half of the applications under review, will be discussed and assigned a priority score, and o Receive a second level of review by the NIOSH Secondary Review Committee. REVIEW CRITERIA The criteria that NIOSH will use to review applications for scientific merit and for meeting program objectives are provided below. In the written comments, reviewers will be asked to discuss the following aspects of your application in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals: o Significance o Approach o Innovation o Investigator o Environment The scientific review group will address and consider each of these criteria in assigning your application"s overall score, weighting them as appropriate for each application. Your application does not need to be strong in all categories to be judged likely to have major scientific impact and thus deserve a high priority score. For example you may propose to carry out important work that, by its nature, is not innovative but essential to move a field forward. (1) Significance: Is the application relevant to the objectives outlined in the RFA? Does the application describe the importance of the proposed surveillance and associated activities in evaluating and reducing occupational injuries, illnesses or hazards? Is the need to link surveillance and prevention activities and the need to integrate occupational health and safety surveillance within existing public health activities well- described? If the aims of the application are achieved, how will state-based occupational safety and health capacity be advanced? Has the applicant described a plan to utilize the surveillance information obtained? (2) Approach: Are the conceptual framework and methods for surveillance and associated activities adequately developed and appropriate to the aims of the project? Are coordination and collaboration with relevant local and state agencies described adequately? Does the applicant provide details about the methods for obtaining and analyzing surveillance data? Does the applicant provide detailed information about the conditions to be included in the surveillance program? Does the applicant acknowledge potential problem areas and consider alternative approaches? Is the time line proposed for the project suitable and realistic? (3) Innovation: Does the project employ innovative concepts, approaches, or objectives for surveillance and associated activities? How does the project expand existing state capacity with new activities or methodologies? (4) Investigators: Are the principal investigator and collaborators appropriately trained and well-suited to carry out this work? Is the surveillance work proposed appropriate to the experience level of the principal investigator and other collaborators? (5) Environment: Are the applicants facilities, equipment, and other resources adequate for the performance of this project? Is there evidence of agency support generally, or specific agency commitment to the development of occupational surveillance and associated activities? Is there documentation of cooperation from relevant local agencies, state agencies, or other participants in the project, where applicable? (6) Other: Reasonableness of the proposed budget and duration in relation to the proposed project. Adequacy of plans to include both genders, minorities and their subgroups, and children as appropriate for the surveillance goals of the project. The adequacy of the proposed protection of humans to the extent that they may be adversely affected by the project proposed in the application. Programmatic Review Criteria (1) Magnitude and severity of the problem in the worker population. (2) Likelihood of developing applied technical knowledge for the prevention of occupational safety and health hazards on a state- wide basis. RECEIPT AND REVIEW SCHEDULE Letter of Intent Receipt Date: May 3, 2002 Application Receipt Date: June 11, 2002 Anticipated Award Date: September 30, 2002 AWARD CRITERIA Award criteria that will be used to make award decisions include: o Scientific merit o Availability of funds o Programmatic priorities REQUIRED FEDERAL CITATIONS INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS: It is the policy of the CDC to ensure that individuals of both sexes and the various racial and ethnic groups will be included in CDC-supported research projects involving human subjects, whenever feasible and appropriate. Racial and ethnic groups are those defined in OMB Directive No. 15 and include American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or other Pacific Islander. Applicants shall ensure that women, racial and ethnic minority populations are appropriately represented in applications for research involving human subjects. Where clear and compelling rationale exist that inclusion is inappropriate or not feasible, this situation must be explained as part of the application. This policy does not apply to research studies when the investigator cannot control the race, ethnicity, and/or sex of subjects. Further guidance to this policy is contained in the Federal Register, Vol. 60, No. 179, pages 47947-47951, and dated Friday, September 15, 1995. All investigators proposing research involving human subjects should read the NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research-Amended, October 9, 2001, published in the NIH Guide for Grants and Contracts on October 9, 2001,, a complete copy of the updated Guidelines are available at 10_2001.htm. INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS: It is the policy of NIH that children (i.e., individuals under the age of 21) must be included in all human subjects research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them. This policy applies to all initial (Type 1) applications submitted for receipt dates after October 1, 1998. This policy will be followed by NIOSH for this announcement. All investigators proposing research involving human subjects should read the NIH Policy and Guidelines, on the inclusion of children as participants in research involving human subjects that is available at Investigators also may obtain copies of these policies from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. REQUIRED EDUCATION ON THE PROTECTION OF HUMAN SUBJECT PARTICIPANTS: If the proposed project involves research on human subjects, the applicant must comply with the Department of Health and Human Services (DHHS) Regulations (Title 45 Code of Federal Regulations Part 46) regarding the protection of human research subjects. All awardees of CDC grants and cooperative agreements and their performances sites engaged in human subjects research must file an assurance of compliance with the regulations and have continuing reviews of the research protocol by appropriate institutional review boards. In order to obtain a federal-wide Assurance (FWA) of Protection for Human Subjects, the applicant must complete an on-line application at the Office for Human Research Protections (OHRP) website or write to the OHRP for an application. OHRP will verify that the signatory official and the Human Subjects Protections Administrator have completed the OHRP Assurance Training/Education Module before approving the FWA. Existing Multiple Project Assurances (MPAs), Cooperative Project Assurances (CPAs), and Single Project Assurances (SPAs) remain in full effect until they expire or until December 31, 2003, whichever comes first. To obtain a FWA contact the OHRP at: or write to: Office for Human Research Protections (OHRP) Department of Health and Human Services 6100 Executive Boulevard, Suite 3B01, MSC 7501 Rockville, Maryland 20892-7507 (Note: For Express or Hand Delivered Mail, Use Zip Code 20852) Note: In addition to other applicable committees, Indian Health Service (IHS) institutional review committees must also review the project if any component of IHS will be involved with or will support the research. If any American Indian community is involved, its tribal government must also approve the applicable portion of that project. Note: Investigators in states with existing statutes covering guidance for the protection of humans, will be asked to submit documentation detailing fully the state authority. If a state does not have statutory authority for all the human subjects activities proposed in the application, the awardee must obtain human subject clearances as described above. The project plan in the application must fully describe the involvement of human subjects and protections. This information should be included in the Human Subjects Research Section of PHS 398. PUBLIC ACCESS TO RESEARCH DATA THROUGH THE FREEDOM OF INFORMATION ACT: The Office of Management and Budget (OMB) Circular A-110 has been revised to provide public access to research data through the Freedom of Information Act (FOIA-45 CFR 74.36) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. Guidance is provided at: Applicants may wish to place data collected under this RFA in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures, given the potential for wider use of data collected under this award. URLS IN NIOSH GRANT APPLICATIONS OR APPENDICES: All applications and proposals must be self-contained within specified page limitations. Unless otherwise specified, internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the internet sites. Reviewers are cautioned that their anonymity may be compromised when they directly access an internet site. LOBBYING RESTRICTIONS: Applicants should be aware of restrictions on the use of Health and Human Services (DHHS) funds for lobbying of Federal or State legislative bodies. Under the provisions of 31 U.S.C. Section 1352, recipients (and their subtier contractors) are prohibited from using appropriated Federal funds (other than profits from a Federal contract) for lobbying congress or any Federal agency in connection with the award of a particular contract, grant, cooperative agreement, or loan. This includes grants/cooperative agreements that, in whole or in part, involve conferences for which Federal funds cannot be used directly or indirectly to encourage participants to lobby or to instruct participants on how to lobby. In addition, no part of the Center for Disease Control and Prevention (CDC) appropriated funds shall be used, other than for normal and recognized executive-legislative relationships, for publicity or propaganda purposes, for the preparation, distribution, or use of any kit, pamphlet, booklet, publication, radio, television, or video presentation designed to support or defeat legislation pending before the Congress or any State or local legislature, except in presentation to the Congress or any State or local legislature itself. No part of the appropriated funds shall be used to pay the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence legislation or appropriations pending before the Congress or any State or local legislature. Any activity designed to influence action in regard to a particular piece of pending legislation would be considered lobbying. That is lobbying for or against pending legislation, as well as indirect or grass roots lobbying efforts by award recipients that are directed at inducing members of the public to contact their elected representatives at the Federal or State levels to urge support of, or opposition to, pending legislative proposals is prohibited. As a matter of policy, CDC extends the prohibitions to lobbying with respect to local legislation and local legislative bodies. The provisions are not intended to prohibit all interaction with the legislative branch, or to prohibit educational efforts pertaining to public health. Clearly, there are circumstances when it is advisable and permissible to provide information to the legislative branch in order to foster implementation of prevention strategies to promote public health. However, it would not be permissible to influence, directly or indirectly, a specific piece of pending legislation. It remains permissible to use CDC funds to engage in activity to enhance prevention, collect and analyze data, publish and disseminate results of research and surveillance data, implement prevention strategies, conduct community outreach services, provide leadership and training, and foster safe and healthful environments. Recipients of CDC grants and cooperative agreements need to be careful to prevent CDC funds from being used to influence or promote pending legislation. With respect to conferences, public events, publication, and grassroots activities that relate to specific legislation, recipients of CDC funds should give attention to isolating and separating the appropriate use of CDC funds from non-CDC funds. CDC also cautions recipients of CDC funds to be careful not to give the appearance that CDC funds are being used to carry out activities in a manner that is prohibited under Federal law. SMOKE-FREE WORKPLACE: CDC strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products, and Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities that receive Federal funds in which education, library, day care, health care, and early childhood development services are provided to children. SMALL, MINORITY, AND WOMEN-OWNED BUSINESS: It is a national policy to place a fair share of purchases with small, minority and women-owned business firms. The Department of Health and Human Services is strongly committed to the objective of this policy and encourages all recipients of its grants and cooperative agreements to take affirmative steps to ensure such fairness. In particular, recipients should: 1. Place small, minority, women-owned business firms on bidders mailing lists. 2. Solicit these firms whenever they are potential sources of supplies, equipment, construction, or services. 3. Where feasible, divide total requirements into smaller needs, and set delivery schedules that will encourage participation by these firms. 4. Use the assistance of the Minority Business Development Agency of the Department of Commerce, the Office of Small and Disadvantaged Business Utilization, DHHS, and similar state and local offices. RESEARCH INTEGRITY: The signature of the institution official on the face page of the application submitted under this Program Announcement is certifying compliance with the Department of Health and Human Services (DHHS) regulations in Title 42 Part 50, Subpart A, entitled Responsibility of PHS Awardee and Applicant Institutions for Dealing with and Reporting Possible Misconduct in Science. The regulation places several requirements on institutions receiving or applying for funds under the PHS Act that are monitored by the DHHS Office of Research Integrity"s (ORI) Assurance Program. For examples: Section 50.103(a) of the regulation states: Each institution that applies for or receives assistance under the Act for any project or program which involves the conduct of biomedical or behavioral research must have an assurance satisfactory to the Secretary (DHHS) that the applicant: (1) Has established an administrative process, that meets the requirements of this subpart, for reviewing, investigating, and reporting allegations of misconduct in science in connection with PHS- sponsored biomedical and behavioral research conducted at the applicant institution or sponsored by the applicant, and (2) Will comply with its own administrative process and the requirements of this Subpart. Section 50.103(b) of the regulation states that: an applicant or recipient institution shall make an annual submission to the [ORI] as follows: (1) The institution"s assurance shall be submitted to the [ORI], on a form prescribed by the Secretary,...and updated annually thereafter...(2) An institution shall submit, along with its annual assurance, such aggregate information on allegations, inquiries, and investigations as the Secretary may prescribe. HEALTHY PEOPLE 2010: CDC is committed to achieving the health promotion and disease prevention objectives of Healthy People 2010, a national activity to reduce morbidity and mortality and improve the quality of life. For a copy of Healthy People 2010, visit the internet site: AUTHORITY AND REGULATIONS: This program is described in the Catalog of Federal Domestic Assistance Number 93.262 for the National Institute for Occupational Safety and Health (NIOSH). This program is authorized under the Public Health Service Act, as amended, Section 301(a) [42 U.S.C. 241(a)], and the Occupational Safety and Health Act of 1970, Section 20(a) [29 U.S.C. 669(a)]. The applicable program regulation is 42 CFR Part 52. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency Review.

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

H H S Department of Health
and Human Services

  N I H National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892